Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Malignant Pleural Mesothelioma
NCT02303899Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Nov 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib, gemcitabine in malignant mesothelioma, sponsored by Humanitas Research Hospital. Started Nov 2014; status: completed.
02
Drugs
imatinibgemcitabine
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT02303899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303899.